Overview

Coronary MDCTA With Iopamidol Injection 370

Status:
Completed

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

Determine the validity and compare the visualization of arterial segments obtained with 3 doses of iopamidol to determine dose for further investigation in future trials.

Phase:

Phase 2

Details

Lead Sponsor:

Bracco Diagnostics, Inc